Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00803335 · ClinicalTrials.gov registry record · Phase 3
The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse
A Phase 3 study, sponsored by TriHealth.
- Completed
- Registry status
- Phase 3
- Development phase
- 54
- Enrollment target
NCT00803335: Completed Phase 3 study, sponsored by TriHealth.
NCT00803335 is a Phase 3 study that has completed, run by TriHealth. The registered enrollment target is 54 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00803335, a Phase 3 study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to find out how long it takes the vagina to respond to hormonal vaginal cream in women with pelvic organ prolapse (bulge in the vagina). It also will address the appropriate amount to use prior to vaginal repair of pelvic organ prolapse.
Interventions
- DRUG Vaginal conjugated estrogen cream 0.5gm
- DRUG Vaginal conjugated estrogen cream 1.0gm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-05 |
| Phase | Phase 3 |
What the finished NCT00803335 record still lists
NCT00803335 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Vaginal conjugated estrogen cream 0.5gm is the first listed.
NCT00803335 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00803335 about?
NCT00803335 is a clinical study titled "The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse". The purpose of this study is to find out how long it takes the vagina to respond to hormonal vaginal cream in women with pelvic organ prolapse (bulge in the vagina). It also will address the appropriate amount to use prior to vaginal repair of pelvic organ prolapse.
What is the current status of trial NCT00803335?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 54 participants. The study started on 2008-12. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00803335?
The interventions under investigation include: Vaginal conjugated estrogen cream 0.5gm (DRUG), Vaginal conjugated estrogen cream 1.0gm (DRUG).
Who is sponsoring clinical trial NCT00803335?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00803335's enrollment target sits among peer trials
54 1838th of 2000 higher than 162 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia